Overview

A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to assess the safety and tolerability of MK-0686 and to evaluate its efficacy in the treatment of osteoarthritis of the hip or knee in men and women.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.